HomeNews Fastened-Period vs Steady CLL Remedy: Balancing Efficacy, High quality of Life, and Prices News September 14, 2024 116 0 Purposeful Precision Drugs: The New Precision Oncology? August 6, 2026 The Story of Immune Checkpoint Inhibitors and Immunotherapy July 21, 2026 Reflections on Progress at ASCO 2026 June 23, 2026 NCI’s Message and High Priorities June 16, 2026 NCI’s Message and High Priorities May 4, 2026 The dialogue will cowl fixed-duration therapies vs steady remedy for CLL and supply a quick overview of venetoclax-based regimens accredited for 12 cycles with obinutuzumab and 24 cycles with rituximab. Share FacebookTwitterPinterestWhatsApp Previous articleEnhertu Demonstrates Total, Intracranial Exercise in HER2-Optimistic Breast Most cancersNext articleCLL Remedy and High quality of Life: Affected person Empowerment and Shared Determination-making Hot Topics Purposeful Precision Drugs: The New Precision Oncology? The Story of Immune Checkpoint Inhibitors and Immunotherapy Reflections on Progress at ASCO 2026 Load more Related Articles Editor - August 6, 2026Purposeful Precision Drugs: The New Precision Oncology? Editor - July 21, 2026The Story of Immune Checkpoint Inhibitors and Immunotherapy Editor - June 23, 2026Reflections on Progress at ASCO 2026 Load more
